Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-9.08 Insider Own0.50% Shs Outstand152.57M Perf Week1.17%
Market Cap9.77B Forward P/E14.84 EPS next Y4.32 Insider Trans30.66% Shs Float148.05M Perf Month-5.51%
Income-1003.90M PEG- EPS next Q0.97 Inst Own97.80% Short Float4.97% Perf Quarter-9.31%
Sales2.46B P/S3.98 EPS this Y21.20% Inst Trans4.23% Short Ratio4.35 Perf Half Y-19.79%
Book/sh18.43 P/B3.47 EPS next Y6.41% ROA-14.20% Target Price75.70 Perf Year57.41%
Cash/sh9.66 P/C6.63 EPS next 5Y6.61% ROE-60.80% 52W Range39.22 - 82.16 Perf YTD-5.10%
Dividend- P/FCF393.85 EPS past 5Y-33.80% ROI-8.50% 52W High-22.08% Beta1.16
Dividend %- Quick Ratio1.30 Sales past 5Y15.70% Gross Margin57.60% 52W Low63.23% ATR1.58
Employees3371 Current Ratio1.50 Sales Q/Q0.90% Oper. Margin22.50% RSI (14)44.95 Volatility1.84% 2.63%
OptionableYes Debt/Eq1.57 EPS Q/Q-37.50% Profit Margin-46.90% Rel Volume0.43 Prev Close65.00
ShortableYes LT Debt/Eq1.51 EarningsJul 31 BMO Payout- Avg Volume1.69M Price64.02
Recom2.10 SMA200.23% SMA50-3.92% SMA200-5.41% Volume731,286 Change-1.51%
01-Aug-14Reiterated Stifel Buy $75 → $84
27-Jun-14Initiated Canaccord Genuity Buy $83
30-Apr-14Initiated National Alliance Securities Buy $76
04-Mar-14Reiterated FBR Capital Mkt Perform $52 → $82
03-Mar-14Reiterated UBS Buy $75 → $90
06-Nov-13Upgrade Needham Underperform → Hold
06-Nov-13Reiterated Stifel Buy $40 → $60
30-Oct-13Initiated FBR Capital Mkt Perform $40
20-Sep-13Reiterated UBS Buy $43 → $50
21-Jun-13Resumed Oppenheimer Perform
06-Jun-13Reiterated UBS Buy $39 → $41
06-Jun-13Reiterated Stifel Buy $36 → $40
06-Jun-13Downgrade Cantor Fitzgerald Hold → Sell $36 → $30
13-May-13Reiterated Stifel Buy $42 → $36
08-May-13Reiterated RBC Capital Mkts Underperform $28 → $29
17-Apr-13Reiterated Stifel Buy $38 → $42
10-Apr-13Downgrade Standpoint Research Buy → Hold
31-Jan-13Reiterated Cantor Fitzgerald Hold $26 → $34
31-Jan-13Downgrade Oppenheimer Outperform → Perform
04-Jan-13Reiterated UBS Buy $42 → $40
27-Aug-14 04:00PM  Glaxo's Promacta Label Now Includes Severe Aplastic Anemia Zacks
08:49AM  Amicus Therapeutics Hits 52-Week High on Migalastat Data Zacks
26-Aug-14 07:50AM  Catalyst Pharmaceutical Partners (CPRX) Worth Watching: Stock Up 10.3% Zacks
25-Aug-14 03:30PM  [$$] Corporate Watch: News Digest at The Wall Street Journal
03:05PM  [$$] Corporate Watch: News Digest at The Wall Street Journal
02:14PM  [$$] Corporate Watch: News Digest at The Wall Street Journal
12:39AM  [$$] Corporate Watch at The Wall Street Journal
12:39AM  [$$] Corporate Watch: News Digest at The Wall Street Journal
22-Aug-14 04:40PM  OncoGenex's Custirsen Passes First Interim Futility Analysis Zacks
04:00PM  AstraZeneca Updates on PLATO Study Investigation on Brilinta Zacks
08:25AM  Flamel Technologies SA (FLML) in Focus: Stock Rises 8% Zacks
21-Aug-14 08:56AM  Gilead (GILD) Hits 52-Week High Thanks to Sovaldi Zacks
20-Aug-14 05:21PM  Alcobra Starts Patient Enrollment for Mid-Stage Study on MDX Zacks
03:45PM  Salix Pharmaceuticals Jumps on Takeover Rumours by Allergan Zacks
08:40AM  Salix Pharmaceuticals (SLXP) Jumps: Stock Moves 15.5% Higher Zacks
18-Aug-14 04:20PM  AstraZeneca's Asthma Drug in Focus, Phase III Study Initiated Zacks
15-Aug-14 03:45PM  AstraZeneca's Gout Drug in Focus with Phase III Data Readout Zacks
14-Aug-14 02:30PM  Rigel's R348 Fails in Phase II Study, Shares Down 13.6% Zacks
09:58AM  Biodel Q3 Loss Narrower than Expected, Gives Pipeline Update Zacks
07:02AM  Jazz Pharmaceuticals (JAZZ) in Focus: Stock Surges 8.8% Zacks
13-Aug-14 12:50PM  BioDelivery Sciences Q2 Loss Narrows, Up on Solid Revenues Zacks
09:40AM  Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus Zacks
08:30AM  AVEO Pharmaceuticals Posts Narrower-than-Expected Q2 Loss Zacks
08:10AM  Athersys Loss In Line with Expectations, Revenues Down Y/Y Zacks
06:53AM  What Makes Durata Therapeutics (DRTX) a Strong Sell? Zacks
12-Aug-14 03:20PM  Tekmira Shares Continue to Rise in the Search for Ebola Cure Zacks
10:30AM  Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 Zacks
09:50AM  Repros Therapeutics Q2 Loss a Penny Wider than Expected Zacks
09:38AM  Supernus (SUPN) Posts Strong Earnings in Q2, Guidance Raised Zacks
08:58AM  Anacor's Q2 Loss Narrower than Expected, Kerydin in Focus Zacks
08:22AM  Cardiome Pharma Corp. (CRME) Jumps: Stock Rises 6.9% Zacks
08:20AM  Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance Zacks
07:05AM  Aratana Therapeutics (PETX) Falls: Stock Goes Down 5.9% Zacks
11-Aug-14 10:50AM  Osiris Falls despite Narrower Q2 Loss and Higher Revenues Zacks
09-Aug-14 01:04PM  ENDO INTERNATIONAL PLC Financials EDGAR Online Financials
08-Aug-14 06:54AM  OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 8.2% Zacks
06:54AM  IGI, Laboratories (IG) Jumps: Stock Adds 6.7% in Session Zacks
07-Aug-14 07:32AM  Jazz Pharmaceuticals (JAZZ) Jumps: Stock Moves 5.2% Higher Zacks
06-Aug-14 05:00PM  Endo completes acquisition of DAVA Pharmaceuticals PR Newswire
09:50AM  QLT Q2 Loss Widens, Focus on Impending Merger with Auxilium Zacks
08:30AM  Earnings Up at Jazz Pharmaceuticals, Revenue Guidance Raised Zacks
06:47AM  Valeant Pharmaceuticals Slumps: VRX Falls 5.3% in Session Zacks
05-Aug-14 05:05PM  Vertex Pharmaceuticals' Kalydeco Label Expanded in EU Zacks
02:50PM  Zoetis Misses Marginally on Q2 Earnings, Up Y/Y, View Adjusted Zacks
10:00AM  Ironwood Pharmaceuticals Narrows Q2 Loss, Revenues Down Zacks
07:04AM  Durata Therapeutics (DRTX) Worth Watching: Stock Gains 18.5% Zacks
06:57AM  Flamel Technologies SA (FLML) Soars: Stock Rises 10.9% Zacks
06:57AM  BioCryst Pharmaceuticals (BCRX) Jumps: Stock Adds 5.4% in Session Zacks
04-Aug-14 05:22PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events EDGAR Online
01:03PM  3 Health Care Stocks Dragging The Sector Down at TheStreet
06:39AM  IGI, Laboratories (IG) Soars: Stock Rises 10.6% Zacks
01-Aug-14 03:25PM  Endo International Beats on Q2 Earnings & Sales, Guidance Up Zacks
08:16AM  AcelRx Pharmaceuticals (ACRX) Soars: Stock Adds 6.8% in Session Zacks
31-Jul-14 08:30AM  Endo International PLC Earnings Call scheduled for 8:30 am ET today CCBN
08:19AM  Endo International PLC Earnings Call scheduled for 8:30 am ET today CCBN
07:54AM  Endo raises forecast, reports better-than-expected profit Reuters
07:35AM  Endo International PLC Earnings Call scheduled for 8:30 am ET today CCBN
07:09AM  Endo tops Wall Street quarterly estimates Reuters
07:07AM  Q2 2014 Endo International PLC Earnings Release - Before Market Open CCBN
06:35AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Prin EDGAR Online
06:30AM  Endo Reports Second Quarter Financial Results PR Newswire
30-Jul-14 04:15PM  Endo appoints Shane M. Cooke to Board of Directors PR Newswire
03:50PM  Will Teva Pharmaceutical (TEVA) Beat Q2 Earnings Estimates? Zacks
07:35AM  Pharmacyclics (PCYC) Jumps: Stock Rises 15% Zacks
07:29AM  QLT Inc. (QLTI) Soars: Stock Adds 7.9% in Session Zacks
28-Jul-14 04:28PM  Will Merck & Co. (MRK) Surprise This Earnings Season? Zacks
04:20PM  Is Pfizer Inc. (PFE) Poised to Beat Earnings Estimates? Zacks
04:10PM  Will Express Scripts Miss Earnings Estimates this Season? Zacks
03:30PM  Will Vertex Pharmaceuticals (VRTX) Loss be Below Estimates? Zacks
02:30PM  Can Hospira (HSP) Keep the Earnings Streak Alive? Zacks
25-Jul-14 01:45PM  Bayer/Amgen's Nexavar Does Not Show Resilience in Study Zacks
24-Jul-14 04:15PM  Endo completes acquisition of Grupo Farmaceutico SomarĀ® PR Newswire
01:58PM  Will AbbVie (ABBV) Surprise This Earnings Season? Zacks
23-Jul-14 04:40PM  Will Alexion Pharmaceuticals (ALXN) Miss This Earnings Season? Zacks
03:34PM  Will Generics Eat Into Eli Lilly's (LLY) Q2 Earnings? Zacks
03:02PM  Will Bristol-Myers Squibb (BMY) Disappoint This Earnings Season? Zacks
22-Jul-14 03:55PM  Celgene (CELG) Set to Beat Earnings Estimates on Strong Revs Zacks
12:50PM  Will Biogen Idec Inc. (BIIB) Surprise this Earnings Season? Zacks
21-Jul-14 07:06AM  AcelRx Pharmaceuticals (ACRX) Jumps: Stock Adds 11.7% in Session Zacks
06:56AM  ImmunoGen (IMGN) Soars: Stock Up 8.8% Zacks
16-Jul-14 07:40AM  Endo's Paladin Labs Reports Canadian Introduction Of Veregen Benzinga
07:30AM  Paladin Labs Announces the Canadian Launch of VeregenĀ® CNW Group
15-Jul-14 09:00AM  Endo to Announce Second Quarter 2014 Financial Results on July 31, 2014 PR Newswire
14-Jul-14 07:34AM  MediWound (MDWD) Falls: Stock Goes Down 6.1% Zacks
08-Jul-14 03:45PM  BioDelivery Jumps after Pain Drug Performs Well in Study Zacks
01:04PM  ENDO INTERNATIONAL PLC Financials EDGAR Online Financials
07-Jul-14 05:03PM  Up 9%: Time to Buy BioDelivery Sciences International, Inc.? at Motley Fool
04:39PM  US STOCKS-Wall St retreats as cyclicals weigh; small-caps sag Reuters
04:37PM  Stocks slip, pulling Dow back near 17,000 AP
03:08PM  Why BioDelivery Sciences International, Inc. Stock Soared at Motley Fool
02:35PM  Stocks fall after market hit milestones AP
01:52PM  US STOCKS-Wall St drops as cyclicals weigh; small-caps lag Reuters
01:47PM  Stocks fall after market hit milestones AP
12:29PM  US STOCKS-Wall St drops as cyclicals and small-cap shares weigh Reuters
12:25PM  Stocks fall after market hit milestones AP
10:56AM  Stocks fall after market hit milestones AP
10:44AM  BioDelivery surges after BEMA buprenorphine study meets primary endpoint at theflyonthewall.com
10:15AM  US STOCKS-Wall St recedes from record, cyclicals fall Reuters
10:10AM  Stocks fall after market hit milestones AP
09:22AM  Stock futures fall after market milestones AP
Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men's and women's health, and prostate health. The company's products also include Aveed, an injectable testosterone preparation to treat male hypogonadism; and BEMA Buprenorphine, a transmucosal form of buprenorphine in Phase III trials for treating moderate to severe chronic pain. It serves pharmacy chains directly; and hospitals, governmental agencies, pharmacies, and physicians through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.